DALLAS, TX - Unique on the market, the S-ICD (Cameron Health/Boston Scientific), an implantable cardioverter-defibrillator (ICD) with a totally subcutaneous lead system, was judged "safe, ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...
The U.S. Food and Drug Administration (FDA) recently granted marketing approval for Boston Scientific Corporation 's BSX Emblem MRI Subcutaneous Implantable Defibrillator (S-ICD) System, in line with ...
Subcutaneous implantable cardioverter defibrillators (S-ICDs) performed on par with conventional transvenous ICDs (TV-ICDs) in the first head-to-head randomized trial. The overall primary composite ...
Boston Scientific ($BSX) played up a data registry study in the Journal of the American College of Cardiology demonstrating the safety of its subcutaneous implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results